If possible, identify a partner organisation or provider in the country from which you wish to obtain genetic resources. Gain information on the conditions that are likely to apply to access and use. Standard conditions probably apply to genetic resources held in a public collection. This will not be the case if you wish to collect genetic resources from the wild or directly from farmers, markets or local traders.
Check, if possible with your counterparts, if the country stipulates that permission must be obtained to access and use its genetic material. If this is required, it will mostly be in the form of prior informed consent (PIC). For many countries, information on access legislation is available on the ABS Clearing-House website. The national focal point (NFP) of a country is responsible for providing information on legislation, rules and procedures governing access to genetic resources from that country. Names and contact details of NFP are available on the ABS Clearing-House website and on the website of the Convention on Biological Diversity (CBD).
Present your plan to the CNA of the providing country and request PIC. You will be expected to have negotiated or negotiate mutually agreed terms (MAT) with the provider or providers, including academics and/or local communities. The CNA will then approve or reject the MAT, on the basis of the instructions it has received. Such approval is often not required for access to public gene banks or other public collections.
Make sure you obtain PIC and MAT, and ask the CNA to inform the CBD of this so that an internationally recognised certificate of compliance can be lodged with the ABS Clearing-House. Document these agreements carefully. If this is not feasible, go through the steps laid down in European Regulation 511/2014, Article 4, paragraph 3 which specifies the information you need to collect to fulfil your obligations in this field.
Use the genetic resources obtained only in accordance with the conditions agreed with the providing country, and carefully document the use you make of them.
Submit a due diligence declaration when you receive a public or private grant for activities in which genetic resources are utilised in the sense of European Regulation 511/2014. You must also submit a due diligence declaration prior to marketing a product for which genetic resources have been utilised in the sense of European Regulation 511/2014. Due diligence declarations can be submitted through the EU-wide tool DECLARE. You can find more information on due diligence declarations in Implementing Regulation 2015/1866, Articles 5, 6 and 7.
Access to and use of materials occurring in situ (‘in nature or in the field’, so not in a collection) in the Netherlands do not in principle require PIC or MAT. However, nature protection law may apply to species or habitats. The Standard Material Transfer Agreement (SMTA) usually applies to plant-genetic resources for food and agriculture held in public collections.
The situation concerning the acquisition and use of varieties that may be protected by plant breeder's rights will be clarified in EU-guidance for the EU-legislation. Until then, it is important to treat varieties accessed in other countries that are protected by plant breeder's rights in the same way as other genetic resources, and check relevant obligations.